Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

Table of Contents

December 1, 2022; Volume 63,Issue 12

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 12A;

Discussions with Leaders

  • You have access
    Leading in Urology and Pioneering in Social Media Outreach
    Declan Murphy, Ken Herrmann and Michael Hofman
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1783-1785; DOI: https://doi.org/10.2967/jnumed.122.265028

The State of the Art

  • You have access
    Fibroblast Activation Protein Inhibitor Imaging in Nonmalignant Diseases: A New Perspective for Molecular Imaging
    Christian Schmidkonz, Torsten Kuwert, Armin Atzinger, Michael Cordes, Georg Schett, Andreas Ramming and Theresa Götz
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1786-1792; DOI: https://doi.org/10.2967/jnumed.122.264205

Continuing Education

  • You have access
    From Concept to Regulatory Drug Approval: Lessons for Theranostics
    Marlon Perera and Michael J. Morris
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1793-1801; DOI: https://doi.org/10.2967/jnumed.121.263301

Focus on Molecular Imaging

  • You have access
    Nanoparticle Diagnostics and Theranostics in the Clinic
    Roger M. Pallares, Felix M. Mottaghy, Volkmar Schulz, Fabian Kiessling and Twan Lammers
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1802-1808; DOI: https://doi.org/10.2967/jnumed.122.263895

Theranostics

  • Clinical

    • Validation of <sup>18</sup>F-rhPSMA-7 and <sup>18</sup>F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      You have access
      Validation of 18F-rhPSMA-7 and 18F-rhPSMA-7.3 PET Imaging Results with Histopathology from Salvage Surgery in Patients with Biochemical Recurrence of Prostate Cancer
      Markus Kroenke, Lilit Schweiger, Thomas Horn, Bernhard Haller, Kristina Schwamborn, Alexander Wurzer, Tobias Maurer, Hans-Jürgen Wester, Matthias Eiber and Isabel Rauscher
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1809-1814; DOI: https://doi.org/10.2967/jnumed.121.263707
    • Using <sup>68</sup>Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
      You have access
      Using 68Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice
      Chloé S. Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R. Sautois and Nadia Withofs
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1815-1821; DOI: https://doi.org/10.2967/jnumed.121.263611
    • <sup>68</sup>Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
      You have access
      68Ga-PSMA-11 PET/MRI in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Adenocarcinoma: PET Findings Correlate with Outcomes After Definitive Treatment
      Farshad Moradi, Heying Duan, Hong Song, Guido A. Davidzon, Benjamin I. Chung, Alan E. C. Thong, Andreas M. Loening, Pejman Ghanouni, Geoffrey Sonn and Andrei Iagaru
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1822-1828; DOI: https://doi.org/10.2967/jnumed.122.263897
    • Correlation of <sup>68</sup>Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
      You have access
      Correlation of 68Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer
      Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn and Andrei Iagaru
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1829-1835; DOI: https://doi.org/10.2967/jnumed.122.263971
    • SPECIAL CONTRIBUTION

      • You have access
        Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center
        Ken Herrmann, Luca Giovanella, Andrea Santos, Jonathan Gear, Pinar Ozgen Kiratli, Jens Kurth, Ana M. Denis-Bacelar, Roland Hustinx, Marianne Patt, Richard L. Wahl, Diana Paez, Francesco Giammarile, Hossein Jadvar, Neeta Pandit-Taskar, Munir Ghesani and Jolanta Kunikowska
        Journal of Nuclear Medicine December 1, 2022, 63 (12) 1836-1843; DOI: https://doi.org/10.2967/jnumed.122.264321
    • Repetitive Early <sup>68</sup>Ga-FAPI PET Acquisition Comparing <sup>68</sup>Ga-FAPI-02, <sup>68</sup>Ga-FAPI-46, and <sup>68</sup>Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      You have access
      Repetitive Early 68Ga-FAPI PET Acquisition Comparing 68Ga-FAPI-02, 68Ga-FAPI-46, and 68Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions
      Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe Haberkorn and Manuel Röhrich
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1844-1851; DOI: https://doi.org/10.2967/jnumed.122.264069
  • Basic

    • A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
      You have access
      A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake
      Andrea Galbiati, Aureliano Zana, Matilde Bocci, Jacopo Millul, Abdullah Elsayed, Jacqueline Mock, Dario Neri and Samuele Cazzamalli
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1852-1858; DOI: https://doi.org/10.2967/jnumed.122.264036
    • FEATURED ARTICLE OF THE MONTH

      • Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
        You have access
        Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
        Megan Minnix, Maciej Kujawski, Erasmus Poku, Paul J. Yazaki, Jeffrey Y. Wong and John E. Shively
        Journal of Nuclear Medicine December 1, 2022, 63 (12) 1859-1864; DOI: https://doi.org/10.2967/jnumed.122.264126

Oncology

  • Clinical

    • <sup>18</sup>F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
      You have access
      18F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors
      Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb and Alessio Imperiale
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1865-1870; DOI: https://doi.org/10.2967/jnumed.122.263984
    • First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using <sup>18</sup>F-labeled Active-Site Inhibited Factor VII (<sup>18</sup>F-ASIS): Potential as Companion Diagnostic
      You have access
      First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using 18F-labeled Active-Site Inhibited Factor VII (18F-ASIS): Potential as Companion Diagnostic
      Mathias Loft, Camilla Christensen, Malene M. Clausen, Esben A. Carlsen, Carsten P. Hansen, Niels Kroman, Seppo W. Langer, Claus Høgdall, Jacob Madsen, Nic Gillings, Carsten H. Nielsen, Thomas L. Klausen, Søren Holm, Annika Loft, Anne K. Berthelsen and Andreas Kjaer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1871-1879; DOI: https://doi.org/10.2967/jnumed.122.264068
    • <sup>89</sup>Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
      You have access
      89Zr-Labeled High-Density Lipoprotein Nanoparticle PET Imaging Reveals Tumor Uptake in Patients with Esophageal Cancer
      Kang H. Zheng, Jeffrey Kroon, Jasper Schoormans, Oliver Gurney-Champion, Sybren L. Meijer, Suzanne S. Gisbertz, Maarten C.C.M. Hulshof, Danielle J. Vugts, Guus A.M.S. van Dongen, Bram F. Coolen, Hein J. Verberne, Aart J. Nederveen, Erik S.G. Stroes and Hanneke W.M. van Laarhoven
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1880-1886; DOI: https://doi.org/10.2967/jnumed.121.263330
    • BRIEF COMMUNICATION

      • You have access
        18F-FDG PET/CT Staging of Head and Neck Cancer: Interobserver Agreement and Accuracy—Results from Multicenter ACRIN 6685 Clinical Trial
        Rathan M. Subramaniam, Fenghai M. Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M. Intenzo, Lilja Solnes, JoRean Sicks, Brendan C. Stack and Val J. Lowe
        Journal of Nuclear Medicine December 1, 2022, 63 (12) 1887-1890; DOI: https://doi.org/10.2967/jnumed.122.263902
    • Safety and Efficacy of <sup>166</sup>Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
      You have access
      Safety and Efficacy of 166Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study
      Margot T.M. Reinders, Karel J. van Erpecum, Maarten L.J. Smits, Arthur J.A.T. Braat, Joep de Bruijne, Rutger Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker and Marnix G.E.H. Lam
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1891-1898; DOI: https://doi.org/10.2967/jnumed.122.263823
    • Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using <sup>18</sup>F-FDG PET
      You have access
      Noninvasive Assessment of Acute Graft-Versus-Host Disease of the Gastrointestinal Tract After Allogeneic Hemopoietic Stem Cell Transplantation Using 18F-FDG PET
      Martin H. Cherk, Robert Khor, Thomas W. Barber, Kenneth S.K. Yap, Sushrut Patil, Patricia Walker, Sharon Avery, Stuart Roberts, William Kemp, Alan Pham, Michael Bailey and Victor Kalff
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1899-1905; DOI: https://doi.org/10.2967/jnumed.121.263688

Cardiovascular

  • Clinical

    • FEATURED CLINICAL INVESTIGATION ARTICLE

      • Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
        You have access
        Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
        Christian Nitsche, Katharina Mascherbauer, Raffaella Calabretta, Matthias Koschutnik, Carolina Dona, Varius Dannenberg, Felix Hofer, Kseniya Halavina, Andreas A. Kammerlander, Tatjana Traub-Weidinger, Georg Goliasch, Christian Hengstenberg, Marcus Hacker and Julia Mascherbauer
        Journal of Nuclear Medicine December 1, 2022, 63 (12) 1906-1911; DOI: https://doi.org/10.2967/jnumed.122.264041

Neurology

  • Basic

    • Evaluation of (<em>rac</em>)-, (<em>R</em>)-, and (<em>S</em>)-<sup>18</sup>F-OF-NB1 for Imaging GluN2B Subunit–Containing <em>N</em>-Methyl-<span class="sc">d</span>-Aspartate Receptors in Nonhuman Primates
      You have access
      Evaluation of (rac)-, (R)-, and (S)-18F-OF-NB1 for Imaging GluN2B Subunit–Containing N-Methyl-d-Aspartate Receptors in Nonhuman Primates
      Hazem Ahmed, Ming-Qiang Zheng, Kelly Smart, Hanyi Fang, Li Zhang, Paul R. Emery, Hong Gao, Jim Ropchan, Ahmed Haider, Gilles Tamagnan, Richard E. Carson, Simon M. Ametamey and Yiyun Huang
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1912-1918; DOI: https://doi.org/10.2967/jnumed.122.263977
  • Translational

    • First-in-Human Evaluation of <sup>18</sup>F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
      You have access
      First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B
      Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia G. Van Buskirk, Madeline D. Jenkins, Jose A. Montero Santamaria, Kevin P. Maresca, Akihiro Takano, Jeih-San Liow, Thomas A. Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoë A. Hughes, Christopher J. Schmidt, Shawn D. Doran, Andrew Mannes, Paolo Zanotti-Fregonara, Maarten Ooms, Cheryl L. Morse, Sami S. Zoghbi, Christer Halldin, Victor W. Pike and Robert B. Innis
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1919-1924; DOI: https://doi.org/10.2967/jnumed.122.263838

AI/Advanced Image Analysis

  • Clinical

    • <sup>18</sup>F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
      Open Access
      18F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients
      Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont and Irène Buvat
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1925-1932; DOI: https://doi.org/10.2967/jnumed.121.263501
    • Distinction of Lymphoma from Sarcoidosis on <sup>18</sup>F-FDG PET/CT: Evaluation of Radiomics-Feature–Guided Machine Learning Versus Human Reader Performance
      You have access
      Distinction of Lymphoma from Sarcoidosis on 18F-FDG PET/CT: Evaluation of Radiomics-Feature–Guided Machine Learning Versus Human Reader Performance
      Pierre Lovinfosse, Marta Ferreira, Nadia Withofs, Alexandre Jadoul, Céline Derwael, Anne-Noelle Frix, Julien Guiot, Claire Bernard, Anh Nguyet Diep, Anne-Françoise Donneau, Marie Lejeune, Christophe Bonnet, Wim Vos, Patrick E. Meyer and Roland Hustinx
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1933-1940; DOI: https://doi.org/10.2967/jnumed.121.263598
    • Fully Automated, Semantic Segmentation of Whole-Body <sup>18</sup>F-FDG PET/CT Images Based on Data-Centric Artificial Intelligence
      You have access
      Fully Automated, Semantic Segmentation of Whole-Body 18F-FDG PET/CT Images Based on Data-Centric Artificial Intelligence
      Lalith Kumar Shiyam Sundar, Josef Yu, Otto Muzik, Oana C. Kulterer, Barbara Fueger, Daria Kifjak, Thomas Nakuz, Hyung Min Shin, Annika Katharina Sima, Daniela Kitzmantl, Ramsey D. Badawi, Lorenzo Nardo, Simon R. Cherry, Benjamin A. Spencer, Marcus Hacker and Thomas Beyer
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1941-1948; DOI: https://doi.org/10.2967/jnumed.122.264063

Endocrinology

  • Translational

    • Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
      Open Access
      Development of Fluorinated NP-59: A Revival of Cholesterol Use Imaging with PET
      Allen F. Brooks, Wade P. Winton, Jenelle Stauff, Janna Arteaga, Bradford Henderson, Jeremy Niedbala, Peter J.H. Scott and Benjamin L. Viglianti
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1949-1955; DOI: https://doi.org/10.2967/jnumed.122.263864

Gastroenterology

  • Basic

    • Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
      You have access
      Staging Liver Fibrosis by Fibroblast Activation Protein Inhibitor PET in a Human-Sized Swine Model
      Ali Pirasteh, Sarvesh Periyasamy, Jennifer Jean Meudt, Yongjun Liu, Laura M. Lee, Kyle M. Schachtschneider, Lawrence B. Schook, Ron C. Gaba, Lu Mao, Adnan Said, Alan Blair McMillan, Paul F. Laeseke and Dhanansayan Shanmuganayagam
      Journal of Nuclear Medicine December 1, 2022, 63 (12) 1956-1961; DOI: https://doi.org/10.2967/jnumed.121.263736

Illustrated Post

  • You have access
    A Long Axial Field of View Enables PET/CT in Toddler Without Sedation
    Michala Reichkendler, Flemming L. Andersen, Lise Borgwardt, Ulrikka Nygaard, Elisabeth Albrecht-Beste, Kim F. Andersen, Anna Ljunggren, Nynne Abrahamsen, Annika Loft, Liselotte Højgaard and Barbara M. Fischer
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 1962; DOI: https://doi.org/10.2967/jnumed.121.263626

Departments

  • You have access
    Recruitment
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 10A;

SNMMI Newsline

  • You have access
    SNMMI Newsline
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 13N-24N;
  • You have access
    2022 SNMMI Highlights Lecture: Oncology and Therapy, Part 1
    Heiko Schöder
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 13N-18N;
  • You have access
    SNMMI Adopts New Strategic Plan
    Munir Ghesani
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 19N-20N;
  • You have access
    NewsBriefs
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 21N;
  • You have access
    From the Literature
    Journal of Nuclear Medicine December 1, 2022, 63 (12) 22N-24N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 63 (12)
Journal of Nuclear Medicine
Vol. 63, Issue 12
December 1, 2022
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)

Issue highlights

  • Improved Tumor Responses with Sequential Targeted α-Particles Followed by Interleukin 2 Immunocytokine Therapies in Treatment of CEA-Positive Breast and Colon Tumors in CEA Transgenic Mice
  • Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy
Sign up for alerts

Jump to

  • This Month in JNM
  • Discussions with Leaders
  • The State of the Art
  • Continuing Education
  • Focus on Molecular Imaging
  • Theranostics
    • Clinical
      • SPECIAL CONTRIBUTION
    • Basic
      • FEATURED ARTICLE OF THE MONTH
  • Oncology
    • Clinical
      • BRIEF COMMUNICATION
  • Cardiovascular
    • Clinical
      • FEATURED CLINICAL INVESTIGATION ARTICLE
  • Neurology
    • Basic
    • Translational
  • AI/Advanced Image Analysis
    • Clinical
  • Endocrinology
    • Translational
  • Gastroenterology
    • Basic
  • Illustrated Post
  • Departments
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • First-in-Human Assessment of 11C-LSN3172176, an M1 Muscarinic Acetylcholine Receptor PET Radiotracer
  • Performance Evaluation of the uEXPLORER Total-Body PET/CT Scanner Based on NEMA NU 2-2018 with Additional Tests to Characterize PET Scanners with a Long Axial Field of View
  • Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients
  • Tumor Response to Radiopharmaceutical Therapies: The Knowns and the Unknowns
  • Is FDG maximum standardized uptake value (SUV max) of primary breast cancer can predict axillary lymph node metastasis?
More...
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire